ad
This Article
Right arrow Images Only
Right arrow Full Version
Right arrow PDF Español
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Articles in Pediatrics
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

Section 3. Summaries of Infectious Diseases

Respiratory Syncytial Virus

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

Top
 Next
CLINICAL MANIFESTATIONS: Respiratory syncytial virus (RSV) causes acute respiratory tract illness in patients of all ages. In infants and young children, RSV is the most important cause of bronchiolitis and pneumonia. During the first few weeks of life, particularly among preterm infants, infection with RSV may produce minimal respiratory tract signs. Lethargy, irritability, and poor feeding, sometimes accompanied by apneic episodes, may be the major manifestations. Most previously healthy infants infected with RSV do not require hospitalization, and many who are hospitalized improve with supportive care and are discharged in fewer than 5 days. Conditions that increase the risk of severe or fatal RSV infection are cyanotic or complicated congenital heart disease, especially conditions causing pulmonary hypertension; underlying pulmonary disease, especially bronchopulmonary dysplasia; prematurity; and immunodeficiency disease or therapy causing immunosuppression at any age. The association between RSV bronchiolitis early in life and subsequent reactive airway disease remains poorly understood. After RSV bronchiolitis, some children will develop long-term abnormalities in pulmonary function and experi ence recurrent wheezing. This association may reflect an underlying predisposition to reactive airway disease rather than a direct consequence of RSV infection.

Almost all children are infected at least once by 2 years of age, and reinfection throughout life is common. Older children and adults usually develop upper respiratory tract illness but also can develop more serious lower respiratory tract infection. Exacerbation of asthma or other chronic lung conditions may occur.


Top
 Previous
Next
ETIOLOGY: Respiratory syncytial virus is an enveloped RNA paramyxovirus that lacks neuraminidase and hemagglutinin surface glycoproteins. Two major subtypes (A and B) have been identified and often circulate concurrently. The clinical and epidemiologic significance of strain variation . . . [Go to Full Text]


Related text in Red Book:

Summary of Major Changes in the 2003 Red Book

Red Book 2003: xxv. [Extract] [Full Version]  

Preterm and Low Birth Weight Infants

Red Book 2003: 66-68. [Extract] [Full Version]  



This topic has been referenced by these articles:

  • Pinto, R. A., Arredondo, S. M., Bono, M. R., Gaggero, A. A., Diaz, P. V. (2006). T Helper 1/T Helper 2 Cytokine Imbalance in Respiratory Syncytial Virus Infection Is Associated With Increased Endogenous Plasma Cortisol. Pediatrics 117: e878-e886 [Abstract] [Full Version]  
  • Bulkow, L. R., Singleton, R. J., Karron, R. A., Harrison, L. H. (2002). Risk Factors for Severe Respiratory Syncytial Virus Infection Among Alaska Native Children. Pediatrics 109: 210-216 [Abstract] [Full Version]  
  • Uzel, G., Premkumar, A., Malech, H. L., Holland, S. M. (2000). Respiratory Syncytial Virus Infection in Patients With Phagocyte Defects. Pediatrics 106: 835-837 [Abstract] [Full Version]  
  • Bockova, J., O'Brien, K. L., Oski, J., Croll, J., Reid, R., Weatherholtz, R. C., Santosham, M., Karron, R. A. (2002). Respiratory Syncytial Virus Infection in Navajo and White Mountain Apache Children. Pediatrics 110: e20-20 [Abstract] [Full Version]  
  • Macartney, K. K., Gorelick, M. H., Manning, M. L., Hodinka, R. L., Bell, L. M. (2000). Nosocomial Respiratory Syncytial Virus Infections: The Cost-Effectiveness and Cost-Benefit of Infection Control. Pediatrics 106: 520-526 [Abstract] [Full Version]  
  • Gavin, P. J., Katz, B. Z. (2002). Intravenous Ribavirin Treatment for Severe Adenovirus Disease in Immunocompromised Children. Pediatrics 110: e9-9 [Abstract] [Full Version]  
  • Choudhuri, J. A., Ogden, L. G., Ruttenber, A. J., Thomas, D. S.K., Todd, J. K., Simoes, E. A.F. (2006). Effect of Altitude on Hospitalizations for Respiratory Syncytial Virus Infection. Pediatrics 117: 349-356 [Abstract] [Full Version]